Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1 DOI Open Access
Issam Ben‐Sahra, Jessica J. Howell, John M. Asara

et al.

Science, Journal Year: 2013, Volume and Issue: 339(6125), P. 1323 - 1328

Published: Feb. 22, 2013

Coordinating Metabolism Growth factors help to coordinate metabolism with growth in part by stimulating the activity of protein kinase mTORC1 (mechanistic target rapamycin complex 1). Ben-Sahra et al. (p. 1323 , published online 21 February) and Robitaille 1320 independently identified a key mTORC1—carbamolyl-phosphate synthase 2, or CAD, rate-limiting enzyme for de novo synthesis pyrimidines. Metabolomic profiling phosphoproteomic analyses normal cells lacking signaling converged on CAD as point at which growth-promoting signals also ramp up production nucleic acids.

Language: Английский

mTOR Signaling in Growth Control and Disease DOI Creative Commons
Mathieu Laplante, David M. Sabatini

Cell, Journal Year: 2012, Volume and Issue: 149(2), P. 274 - 293

Published: April 1, 2012

Language: Английский

Citations

7814

mTOR Signaling in Growth, Metabolism, and Disease DOI Creative Commons
Robert A. Saxton, David M. Sabatini

Cell, Journal Year: 2017, Volume and Issue: 168(6), P. 960 - 976

Published: March 1, 2017

Language: Английский

Citations

6377

AKT/PKB Signaling: Navigating the Network DOI Creative Commons
Brendan D. Manning, Alex Toker

Cell, Journal Year: 2017, Volume and Issue: 169(3), P. 381 - 405

Published: April 1, 2017

Language: Английский

Citations

3066

Mechanisms of Insulin Action and Insulin Resistance DOI Open Access
Max C. Petersen, Gerald I. Shulman

Physiological Reviews, Journal Year: 2018, Volume and Issue: 98(4), P. 2133 - 2223

Published: Aug. 1, 2018

The 1921 discovery of insulin was a Big Bang from which vast and expanding universe research into action resistance has issued. In the intervening century, some discoveries have matured, coalescing solid fertile ground for clinical application; others remain incompletely investigated scientifically controversial. Here, we attempt to synthesize this work guide further mechanistic investigation inform development novel therapies type 2 diabetes (T2D). rational such necessitates detailed knowledge one key pathophysiological processes involved in T2D: resistance. Understanding resistance, turn, requires normal action. review, both physiology pathophysiology are described, focusing on three target tissues: skeletal muscle, liver, white adipose tissue. We aim develop an integrated physiological perspective, placing intricate signaling effectors that carry out cell-autonomous response context tissue-specific functions generate coordinated organismal response. First, section II, effects direct, tissue reviewed, beginning at receptor working downstream. Section III considers critical underappreciated role crosstalk whole body action, especially essential interaction between lipolysis hepatic gluconeogenesis. is then described IV. Special attention given pathways become resistant setting chronic overnutrition, alternative explanation phenomenon ‟selective resistanceˮ presented. Sections V, VI, VII critically examine evidence against several putative mediators V reviews linking bioactive lipids diacylglycerol, ceramide, acylcarnitine resistance; VI impact nutrient stresses endoplasmic reticulum mitochondria discusses non-cell autonomous factors proposed induce including inflammatory mediators, branched-chain amino acids, adipokines, hepatokines. Finally, VIII, propose model links these final common metabolite-driven gluconeogenesis ectopic lipid accumulation.

Language: Английский

Citations

2251

The PI3K Pathway in Human Disease DOI Creative Commons
David A. Fruman, Honyin Chiu, Benjamin D. Hopkins

et al.

Cell, Journal Year: 2017, Volume and Issue: 170(4), P. 605 - 635

Published: Aug. 1, 2017

Language: Английский

Citations

2207

mTOR at the nexus of nutrition, growth, ageing and disease DOI
Grace Y. Liu, David M. Sabatini

Nature Reviews Molecular Cell Biology, Journal Year: 2020, Volume and Issue: 21(4), P. 183 - 203

Published: Jan. 14, 2020

Language: Английский

Citations

2101

Mass-spectrometric exploration of proteome structure and function DOI
Ruedi Aebersold, Matthias Mann

Nature, Journal Year: 2016, Volume and Issue: 537(7620), P. 347 - 355

Published: Sept. 1, 2016

Language: Английский

Citations

1919

The functions and regulation of the PTEN tumour suppressor DOI

Min Sup Song,

Leonardo Salmena, Pier Paolo Pandolfi

et al.

Nature Reviews Molecular Cell Biology, Journal Year: 2012, Volume and Issue: 13(5), P. 283 - 296

Published: April 4, 2012

Language: Английский

Citations

1829

mTOR: a pharmacologic target for autophagy regulation DOI Open Access
Young Chul Kim, Kun‐Liang Guan

Journal of Clinical Investigation, Journal Year: 2015, Volume and Issue: 125(1), P. 25 - 32

Published: Jan. 1, 2015

mTOR, a serine/threonine kinase, is master regulator of cellular metabolism. mTOR regulates cell growth and proliferation in response to wide range cues, its signaling pathway deregulated many human diseases. also plays crucial role regulating autophagy. This Review provides an overview the pathway, mechanisms autophagy regulation, clinical implications inhibitors disease treatment.

Language: Английский

Citations

1772

A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB DOI
Carmine Settembre, Roberto Zoncu, Diego L. Medina

et al.

The EMBO Journal, Journal Year: 2012, Volume and Issue: 31(5), P. 1095 - 1108

Published: Feb. 17, 2012

Language: Английский

Citations

1740